Zhengning Lin

1.0k total citations
10 papers, 645 citations indexed

About

Zhengning Lin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhengning Lin has authored 10 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhengning Lin's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Pneumonia and Respiratory Infections (2 papers) and Pituitary Gland Disorders and Treatments (2 papers). Zhengning Lin is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Pneumonia and Respiratory Infections (2 papers) and Pituitary Gland Disorders and Treatments (2 papers). Zhengning Lin collaborates with scholars based in United States, Italy and Germany. Zhengning Lin's co-authors include George Dailey, Andreas Fritsche, Alan Salzman, Julio Rosenstock, Massimo Massi‐Benedetti, Elizabeth A. Fagan, Williamson Z. Bradford, Ian Glaspole, Marilyn K. Glassberg and Steven D. Nathan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Thorax.

In The Last Decade

Zhengning Lin

10 papers receiving 619 citations

Peers

Countries citing papers authored by Zhengning Lin

Since Specialization

Citations

This map shows the geographic impact of Zhengning Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengning Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengning Lin more than expected).

Fields of papers citing papers by Zhengning Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengning Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengning Lin. The network helps show where Zhengning Lin may publish in the future.

Co-authorship network of co-authors of Zhengning Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengning Lin. A scholar is included among the top collaborators of Zhengning Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengning Lin. Zhengning Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES) 2021 ·Journal of Patient-Reported Outcomes ·Meryl Brod, Lori McLeod, Denka Markova, Jill Gianettoni, (unknown), Zhengning Lin, Aimee D Shu, Alden Smith	10
2	Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency 2021 ·Journal of the Endocrine Society ·Zhengning Lin, Aimee D Shu, Mark A. Bach, Bradley S. Miller, Alan D. Rogol	17
3	Weekly Lonapegsomatropin in Treatment–Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Paul Thornton, Aristides K Maniatis, (unknown), (unknown), Elpis Vlachopapadopoulou, Zhengning Lin, (unknown), (unknown), Vibeke Breinholt, (unknown), (unknown), (unknown), Paul L. Hofman, David Karpf, Aimee D Shu, Michael Beckert	40
4	Placebo‐controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy 2018 ·Annals of Clinical and Translational Neurology ·Craig M. McDonald, Brenda Wong, Kevin M. Flanigan, Rosamund Wilson, S. de Kimpe, Afrodite Lourbakos, Zhengning Lin, (unknown), (unknown)	29
5	Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis 2016 ·Thorax ·Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert Fishman, Ian Glaspole, Marilyn K. Glassberg, (unknown), Talmadge E. King, Lisa Lancaster, David J. Lederer, Zhengning Lin, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Paul W. Noble, Athol U. Wells	131
6	Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials 2016 ·BMJ Open Respiratory Research ·Lisa Lancaster, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert Fishman, Ian Glaspole, Marilyn K. Glassberg, Talmadge E. King, David J. Lederer, Zhengning Lin, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Paul W. Noble	95
7	A Double-Blind, Randomized, Multicenter, Dose-Ranging Study to Evaluate the Safety and Efficacy of Fospropofol Disodium as an Intravenous Sedative for Colonoscopy in High-Risk Populations 2012 ·American Journal of Therapeutics ·Sergio D. Bergese, (unknown), (unknown), Andrew Satlin, Zhengning Lin, Keith Candiotti, (unknown), (unknown)	11
8	Reduced Hypoglycemia Risk With Insulin Glargine 2005 ·Diabetes Care ·Julio Rosenstock, George Dailey, Massimo Massi‐Benedetti, Andreas Fritsche, Zhengning Lin, Alan Salzman	275
9	The Number of Centers in a Multicenter Clinical Study: Effects on Statistical Power 2000 ·Drug Information Journal ·Zhengning Lin	7
10	An issue of statistical analysis in controlled multi-centre studies: how shall we weight the centres? 1999 ·Statistics in Medicine ·Zhengning Lin	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact